MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, ALLO has $395,958K in assets. $117,083K in debts. $30,309K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
964.68%
Quick Ratio
964.68%
Cash Ratio
106.99%
Debt to Asset Ratio
29.57%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Operating lease right-of-use ass...
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Lease liability, noncurrent
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
30,309 51,688 37,815 52,332
Short-term investments
236,577 198,522 214,379 220,788
Prepaid expenses and other current assets
6,407 7,539 8,525 9,535
Total current assets
273,293 257,749 260,719 282,655
Long-term investments
0 8,043 24,944 29,510
Operating lease right-of-use asset
38,819 39,888 40,935 41,966
Property and equipment, net
70,023 72,839 75,896 78,858
Deposit placed in escrow
0 23,479 23,472 23,484
Restricted cash
10,292 10,292 10,292 10,292
Other long-term assets
3,531 3,615 3,513 3,828
Total assets
395,958 415,905 439,771 470,593
Accounts payable
4,933 4,270 3,699 4,851
Accrued and other current liabilities
23,397 28,244 28,134 26,824
Total current liabilities
28,330 32,514 31,833 31,675
Lease liability, noncurrent
72,633 75,045 77,134 79,241
Other long-term liabilities
16,120 15,804 15,475 15,116
Total liabilities
117,083 123,363 124,442 126,032
Common stock, 0.001 par value 400,000,000 shares authorized as of march31, 2026 and december31, 2025 244,816,413 and 229,413,523 shares issued and outstanding as of march31, 2026 and december31, 2025, respectively
245 229 223 220
Additional paid-in capital
2,332,129 2,302,753 2,286,770 2,274,885
Accumulated deficit
-2,053,316 -2,010,709 -1,971,899 -1,930,499
Accumulated other comprehensive income (loss)
-183 269 235 -45
Total stockholders equity
278,875 292,542 315,329 344,561
Total liabilities and stockholders equity
395,958 415,905 439,771 470,593
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$236,577K Cash and cashequivalents$30,309K Prepaid expenses andother current assets$6,407K Total current assets$273,293K Property and equipment,net$70,023K Operating leaseright-of-use asset$38,819K Restricted cash$10,292K Other long-termassets$3,531K Total assets$395,958K Total liabilities andstockholders equity$395,958K Total stockholdersequity$278,875K Total liabilities$117,083K Accumulated deficit-$2,053,316K Accumulated othercomprehensive income (loss)-$183K Additional paid-in capital$2,332,129K Lease liability,noncurrent$72,633K Total currentliabilities$28,330K Other long-termliabilities$16,120K Common stock, 0.001 parvalue 400,000,000...$245K Accrued and othercurrent liabilities$23,397K Accounts payable$4,933K

Allogene Therapeutics, Inc. (ALLO)

Allogene Therapeutics, Inc. (ALLO)